FR2413089A1 - Composition de traitement de l'hypertension - Google Patents

Composition de traitement de l'hypertension

Info

Publication number
FR2413089A1
FR2413089A1 FR7834359A FR7834359A FR2413089A1 FR 2413089 A1 FR2413089 A1 FR 2413089A1 FR 7834359 A FR7834359 A FR 7834359A FR 7834359 A FR7834359 A FR 7834359A FR 2413089 A1 FR2413089 A1 FR 2413089A1
Authority
FR
France
Prior art keywords
group
treatment composition
hypertension treatment
hydroxy
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7834359A
Other languages
English (en)
French (fr)
Other versions
FR2413089B1 (no
Inventor
Zola P Horovitz
Bernard Rubin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25343256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2413089(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of FR2413089A1 publication Critical patent/FR2413089A1/fr
Application granted granted Critical
Publication of FR2413089B1 publication Critical patent/FR2413089B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7834359A 1977-12-27 1978-12-06 Composition de traitement de l'hypertension Granted FR2413089A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86442877A 1977-12-27 1977-12-27

Publications (2)

Publication Number Publication Date
FR2413089A1 true FR2413089A1 (fr) 1979-07-27
FR2413089B1 FR2413089B1 (no) 1980-12-26

Family

ID=25343256

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7834359A Granted FR2413089A1 (fr) 1977-12-27 1978-12-06 Composition de traitement de l'hypertension

Country Status (30)

Country Link
JP (1) JPS54110333A (no)
AR (1) AR230378A1 (no)
AU (1) AU526239B2 (no)
BE (1) BE873092A (no)
CA (1) CA1120400A (no)
CH (1) CH642542A5 (no)
DE (1) DE2854316C3 (no)
DK (1) DK578778A (no)
EG (1) EG14178A (no)
FI (1) FI783991A (no)
FR (1) FR2413089A1 (no)
GB (1) GB2010675B (no)
GR (1) GR72951B (no)
HK (1) HK45483A (no)
HU (1) HU178747B (no)
IE (1) IE48306B1 (no)
IL (1) IL56281A (no)
IT (1) IT1202811B (no)
KE (1) KE3235A (no)
LU (1) LU80709A1 (no)
MY (2) MY8300240A (no)
NL (2) NL192870C (no)
NO (1) NO784357L (no)
NZ (1) NZ189159A (no)
PH (1) PH22111A (no)
PL (1) PL212188A1 (no)
PT (1) PT68983A (no)
SE (1) SE445173B (no)
SG (1) SG41482G (no)
ZA (1) ZA786948B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5829950B2 (ja) * 1978-10-05 1983-06-25 ウェルファイド株式会社 環状イミノカルボン酸誘導体およびその塩類
US4350704A (en) 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4482725A (en) * 1980-04-03 1984-11-13 E. R. Squibb & Sons, Inc. S-Acylation products of mercaptoacyl amino acids and carboxyl group containing diuretics
US4344949A (en) 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4532342A (en) * 1981-02-20 1985-07-30 Warner-Lambert Company N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4552889A (en) * 1983-06-09 1985-11-12 Eli Lilly And Company 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
DE3532036A1 (de) * 1985-09-09 1987-03-26 Hoechst Ag Pharmazeutische zubereitung zur behandlung des bluthochdrucks
DK9200258U4 (da) * 1992-03-11 1993-07-23 Merck & Co Inc Farmaceutisk præparat indeholdende enalapril til brug mod hypertension
WO1996024358A1 (en) * 1995-02-10 1996-08-15 G.D. Searle & Co. Use of low dose amount of spironolactone for treatment of cardiovascular disease

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2340932A1 (fr) * 1976-02-13 1977-09-09 Squibb & Sons Inc Derives de proline et composes apparentes, utiles pour reduire la tension sanguine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2340932A1 (fr) * 1976-02-13 1977-09-09 Squibb & Sons Inc Derives de proline et composes apparentes, utiles pour reduire la tension sanguine

Also Published As

Publication number Publication date
PH22111A (en) 1988-06-01
AR230378A1 (es) 1984-04-30
CA1120400A (en) 1982-03-23
NZ189159A (en) 1984-12-14
GB2010675A (en) 1979-07-04
NL980017I1 (nl) 1998-07-01
IE782413L (en) 1979-06-27
AU4204178A (en) 1979-07-05
IT7831266A0 (it) 1978-12-22
NL7812164A (nl) 1979-06-29
IE48306B1 (en) 1984-12-12
PT68983A (en) 1979-01-01
IL56281A (en) 1983-05-15
KE3235A (en) 1982-11-05
NL192870C (nl) 1998-04-02
AU526239B2 (en) 1982-12-23
MY8300240A (en) 1983-12-31
DE2854316A1 (de) 1979-07-05
GR72951B (no) 1984-01-17
NL192870B (nl) 1997-12-01
CH642542A5 (de) 1984-04-30
ZA786948B (en) 1980-04-30
HU178747B (en) 1982-06-28
FI783991A (fi) 1979-06-28
DK578778A (da) 1979-06-28
JPS54110333A (en) 1979-08-29
SE7813277L (sv) 1979-06-28
EG14178A (en) 1984-06-30
DE2854316C3 (de) 1994-12-22
BE873092A (fr) 1979-06-27
IL56281A0 (en) 1979-03-12
SE445173B (sv) 1986-06-09
GB2010675B (en) 1982-06-16
NO784357L (no) 1979-06-28
HK45483A (en) 1983-10-28
SG41482G (en) 1985-01-11
LU80709A1 (de) 1979-04-13
FR2413089B1 (no) 1980-12-26
PL212188A1 (no) 1980-02-11
IT1202811B (it) 1989-02-09
MY102991A (en) 1993-03-31
DE2854316C2 (no) 1989-08-10
JPS647045B2 (no) 1989-02-07

Similar Documents

Publication Publication Date Title
FR2439790A1 (fr) Phosphinylalcanoyl prolines a action therapeutique, et leurs procedes de preparation
FR2409992A1 (fr) Nouveaux 2-halomethyl-5-vinyl-1,3,4-oxadiazoles
GB1164825A (en) New N-Substituted Nitro-Anilines
FR2372219A1 (fr) Compositions anti-solaires
FR2413089A1 (fr) Composition de traitement de l'hypertension
ES2004256A6 (es) Una composicion antioxidante a base de compuestos hidroxiarilicos y aminoarilicos.
FR2412569A1 (fr) Steroides, leur preparation et leur utilisation therapeutique
FR2361328A1 (fr) Nouvelles benzophenones utiles notamment a la preparation d'oximes et d'hydrazones
TW335334B (en) Compositions having synergistic fungitoxic effects
FR2409988A1 (fr) Pyrazoles substitues en position 4, leur preparation et leur utilisation therapeutique
ATE73814T1 (de) Ammine-n-heterocyclische platinkomplexe und antitumormittel.
FR2411810A1 (fr) Compositions additives pour melanges a base de platre de gypse ou anhydrite
FR2403077A1 (fr) Preparation cosmetique contenant du tripalmitate de pyridoxine
FR2385760A1 (fr) Polymeres organometalliques fortement conducteurs
FR2636946A1 (fr) ((diarylmethoxy)alcoyl)-1 pyrrolidines et piperidines, procedes de preparation et medicaments les contenant
DK341985A (da) Antihoste og slimregulerende 2-substituerede thiazolidiner
FR2358141A1 (fr) Nouveaux anesthesiques locaux
ATE50773T1 (de) Alkylresorcinolphosphite.
FR2411843A1 (fr) Nouvelles 6-deoxyneamines eventuellement 1-n-alkylees et intermediaires necessaires a leur preparation
EP0815111A4 (en) N-ACETYLARDEEMINE ANALOGS, METHODS OF PREPARATION AND USE OF SAID ANALOGS
FR2381746A1 (fr) Nouveaux derives encephaliniques a la methionine
FR2364204A1 (fr) Nouveaux metaaminophenols et compositions tinctoriales les contenant
FR2407941A1 (fr) Nouveaux derives de cholesterol
GB1045031A (en) Dentifrice
FR2447375A1 (fr) Analogues de la prostaglandine e1 et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0095, 920424

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0095, 781206

CL Concession to grant licences